Uterine fibroids - a literature review
DOI:
https://doi.org/10.12775/JEHS.2024.59.009Keywords
Uterine fibroids, clinical manifestations, risk factors, diagnosis and treatment of uterine fibroidsAbstract
Uterine fibroids are the most common benign neoplastic lesions occurring in women. They are formed as a result of proliferation of smooth muscle tissue cells. Their appearance and proliferation are influenced by both genetic and environmental factors. 70% of them remain asymptomatic, so they are often detected only during a routine gynecological examination or pelvic imaging studies. Uterine myomas can generate pelvic and lower abdominal discomfort and pain, abnormal, prolonged, heavy bleeding, anemia, dyspareunia, frequent urination, bloating, constipation, abdominal cramps, low back pain and obstetric complications. Available therapeutic strategies include conservative, pharmacological and surgical treatment. The choice of a particular method is considered on an individual basis and depends on the presence of clinical symptoms, the size, location of the myomas, or the age and procreative plans of the patient.
References
Rezk A, Kahn J, Singh M. Fertility Sparing Management in Uterine Fibroids. 2023 Apr 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 34662018.
https://www.acog.org/womens-health/faqs/uterine-fibroids. Last updated: July 2022 Last reviewed: November 2021
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin Obstet Gynecol. 2016 Mar;59(1):2-24. doi: 10.1097/GRF.0000000000000164. PMID: 26744813; PMCID: PMC4733579.
Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003 Dec;80(6):1488-94. doi: 10.1016/s0015-0282(03)02207-6. PMID: 14667888.
Al-Hendy A, Myers ER, Stewart E. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017 Nov;35(6):473-480. doi:10.1055/s-0037-1607264. Epub 2017 Nov 3. PMID: 29100234; PMCID: PMC6193285.
Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017 Sep;124(10):1501-1512. doi: 10.1111/1471-0528.14640. Epub 2017 May 13. PMID: 28296146.
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99. PMID: 12548202.
Sommer EM, Balkwill A, Reeves G, Green J, Beral DV, Coffey K; Million Women Study Collaborators. Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women. Eur J Epidemiol. 2015 Jun;30(6):493-9. doi: 10.1007/s10654-015-0016-7. Epub 2015 Mar 18. PMID: 25784364; PMCID: PMC4485678.
Paffoni A, Somigliana E, Vigano' P, Benaglia L, Cardellicchio L, Pagliardini L, Papaleo E, Candiani M, Fedele L. Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab. 2013 Aug;98(8):E1374-8. doi: 10.1210/jc.2013-1777. Epub 2013 Jul 3. PMID: 23824422.
Terazra M, Szymańska-Majchrzak J, Sentkowska A, Kilian K, Rogulski Z, Nowicka G, Jakil G, Tomaszewski P, Włodarczyk M. Alpha-Tocopherol Serum Levels Are Increased in Caucasian Women with Uterine Fibroids: A Pilot Study. Biomed Res Int. 2018 Jul 24;2018:6793726. doi: 10.1155/2018/6793726. PMID: 30140700; PMCID: PMC6081575.
Yang Q, Trzecia M, Bariani MV, Ali M, Elkafas H, Boyer TG, Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022 Jul 13;43(4):678-719. doi: 10.1210/endrev/bnab039. Erratum in: Endocr Rev. 2022 Mar 02;: Erratum in: Endocr Rev. 2022 Mar 02;: PMID: 34741454; PMCID: PMC9277653.
Chiaffarino F, Parazzini F, La Vecchia C, Marsico S, Surace M, Ricci E. Use of oral contraceptives and uterine fibroids: results from a case-control study. Br J Obstet Gynaecol. 1999 Aug;106(8):857-60. doi: 10.1111/j.1471-0528.1999.tb08409.x. PMID: 10453838.
Park MJ, Shen H, Kim NH, Gao F, Failor C, Knudtson JF, McLaughlin J, Halder SK, Heikkinen TA, Vahteristo P, Al-Hendy A, Schenken RS, Boyer TG. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas. J Clin Endocrinol Metab. 2018 Nov 1;103(11):4283-4292. doi: 10.1210/jc.2018-00863. PMID: 30099503; PMCID: PMC6194812.
Heinonen HR, Pasanen A, Heikinheimo O, Tanskanen T, Palin K, Tolvanen J et al. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Scientific Reports. 2017 Apr 21;7:1015. doi:10.1038/s41598-017-01199-0.
Holdsworth-Carson SJ, Zaitseva M, Vollenhoven BJ, Rogers PA. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod. 2014 Mar;20(3):250-9. doi: 10.1093/molehr/gat083. Epub 2013 Nov 15. PMID: 24243625.
Wu X, Serna VA, Thomas J, Qiang W, Blumenfeld ML, Kurita T. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma. Cancer Res. 2017 Dec 15;77(24):6891-6901. doi: 10.1158/0008-5472.CAN-17-1744. Epub 2017 Oct 20. PMID: 29055020; PMCID: PMC6015476.
Pérot G, Croce S, Ribeiro A, Lagarde P, Velasco V, Neuville A, Coindre JM, Stoeckle E, Floquet A, MacGrogan G, Chibon F. MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One. 2012;7(6):e40015. doi: 10.1371/journal.pone.0040015. Epub 2012 Jun 29. PMID: 22768200; PMCID: PMC3386951.
Wheeler KC, Warr DJ, Warsetsky SI, Barmat LI. Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer. Fertil Steril. 2016 Jan;105(1):144-8. doi: 10.1016/j.fertnstert.2015.09.034. Epub 2015 Oct 19. PMID: 26493120.
Moroni RM, Vieira CS, Ferriani RA, Reis RM, Nogueira AA, Brito LG. Presentation and treatment of uterine leiomyoma in adolescence: a systematic review. BMC Womens Health. 2015 Jan 22;15:4. doi: 10.1186/s12905-015-0162-9. PMID: 25609056; PMCID: PMC4308853.
Awiwi MO, Badawy M, Shaaban AM, Menias CO, Horowitz JM, Soliman M, Jensen CT, Gaballah AH, Ibarra-Rovira JJ, Feldman MK, Wang MX, Liu PS, Elsayes KM. Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification. Abdom Radiol (NY). 2022 Jul;47(7):2468-2485. doi: 10.1007/s00261-022-03545-x. Epub 2022 May 13. PMID: 35554629.
Russo C, Camilli S, Martire FG, Di Giovanni A, Lazzeri L, Malzoni M, Zupi E, Exacoustos C. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology. Ultrasound Obstet Gynecol. 2022 Aug;60(2):269-276. doi: 10.1002/uog.24855. PMID: 35018681.
Lasmar RB, Lasmar BP, Moawad NS. HYSTEROSCOPIC MYOMECTOMY. Medicina (Kaunas). 2022 Nov 11;58(11):1627. doi: 10.3390/medicina58111627. PMID: 36422166; PMCID: PMC9692806.
Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G. Uterine fibroids: an update on current and emerging medical treatment options. Ther Clin Risk Manag. 2019 Jan 23;15:157-178. doi: 10.2147/TCRM.S147318. PMID: 30774352; PMCID: PMC6350833.
Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012 Feb 2;366(5):409-20. doi: 10.1056/NEJMoa1103182. PMID: 22296075.
Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;(2):CD000547. doi: 10.1002/14651858.CD000547. Update in: Cochrane Database Syst Rev. 2017 Nov 15;11:CD000547. PMID: 11405968.
Pitter MC, Simmonds C, Seshadri-Kreaden U, Hubert HB. The impact of different surgical modalities for hysterectomy on satisfaction and patient reported outcomes. Interact J Med Res. 2014 Jul 17;3(3):e11. doi: 10.2196/ijmr.3160. PMID: 25048103; PMCID: PMC4129130.
Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014 Oct 21;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3. PMID: 25331441.
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014 Dec 26;(12):CD005073. doi: 10.1002/14651858.CD005073.pub4. PMID: 25541260.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Karolina Pokora, Szymon Pokora, Adam Podsiedlik, Agata Stefanowicz, Alicja Poloczek, Jakub Szczerba, Katarzyna Jeleń, Paweł Sojka, Dominika Pokładnik, Tatiana Żymła
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 402
Number of citations: 0